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Abstract
Background: Infections by Staphylococcus spp. are often associated with wounds, especially in hospitalized patients.
Wounds may be the source of bacteria causing cross-contamination, and are a risk factor for methicillin-resistant
Staphylococcus aureus (MRSA) infection. The aim of this study was to investigate the prevalence of wound colonization
by Staphylococcus spp., especially S. aureus and MRSA, in hospitalized patients, and to identify the factors associated
with such colonization.
Methods: This cross-sectional study enrolled patients with wounds who were hospitalized in a remote and
underdeveloped inland region of northeastern Brazil with extreme poverty. Samples were collected using sterile
swabs with 0.85% saline solution, and coagulase-negative Staphylococcus spp., S. aureus, and MRSA were identified
using standard laboratory procedures. Data regarding the sociodemographic characteristics, antibiotic use, and
comorbidities of the patients were collected using the medical records and a questionnaire.
Results: A total of 125 wounds were analyzed. The patients had a mean age of 63.88 years and a mean 3.84 years
of school education. Eighty-one wounds (64.80%) were colonized by Staphylococcus spp. Twenty-five wounds (20%)
were colonized by S. aureus, 32% of which were colonized by MRSA. Wound colonization by Staphylococcus spp. was
associated with pneumonia or other respiratory disease (p = 0.03). Wound colonization by S. aureus was associated
with nasal colonization by S. aureus (p < 0.001), fewer days of prior antibiotic use (p = 0.04), admission to a medical
ward (p = 0.02), and age >65 years (p = 0.05). Among patients with wound colonization by MRSA, 37.50% had a history
of prior antibiotic use, 75% had two or more comorbidities, 25% had cancer or diabetes, 50% had cardiovascular disease,
and 50% died.
Conclusions: Wounds can be the source of Staphylococcus spp. infection, and high proportions of wounds are
colonized by S. aureus and MRSA. Nasal colonization by S. aureus may be a source for wound colonization by S. aureus,
illustrating the importance of preventing cross-contamination in hospital environments, especially among elderly
patients. Wounds should be carefully managed to prevent microbial spread, thereby assisting patient recovery
and reducing healthcare costs.
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Background
Infections by Staphylococcus spp. are common in devel-
oping countries [1]. Variations in antimicrobial suscepti-
bility make it difficult to determine the infection patterns
of Staphylococcus spp. in socioeconomically underdevel-
oped regions [2,3]. Hospitalization of patients increases
their risk of infection, and hospital-acquired infec-
tions are associated with higher mortality rates, longer
hospitalization periods, and increased healthcare costs
compared with community-acquired infections [4,5].
The wounds of hospitalized patients may result from
surgery, pressure ulcers, diabetic ulcers, or hospital- or
community-acquired injuries, and wound infections can
result in recurrent hospitalization. The relative frequencies
of organisms causing wound infections varying greatly
among studies. Staphylococcus aureus and Pseudomonas
aeruginosa are among the organisms most commonly
isolated from severe wounds, and colonization by these
organisms requires careful management because of their
ability to acquire antibiotic resistance and their associ-
ation with nosocomial infections [6-13]. Wounds are a
risk factor for colonization with methicillin-resistant
S. aureus (MRSA) and other multidrug-resistant or-
ganisms, especially in hospital environments [14-18].
Bacterial colonization of wounds can increase wound
severity and interfere with healing [6,11].
Even though skin and soft tissue infections are com-
mon in hospitalized patients [19], few epidemiological or
clinical studies of these infections have been reported
[4], especially studies focusing on the characteristics of
specific healthcare systems or regions. Infections with
antibiotic-resistant bacteria are associated with prolonged
hospitalization, increased morbidity and mortality, and
increased healthcare costs [4,5,20]. Investigation of the pat-
tern of infection by Staphylococcus spp. in a hospital envir-
onment is therefore warranted, especially in wounds,
which may be a source of cross-contamination by MRSA
and coagulase-negative Staphylococcus spp. [11,15,18].
Lack of infrastructure and research funding have re-
sulted in a lack of healthcare studies in northeastern
Brazil, which has some of the poorest socioeconomic
conditions in the country [21], especially in inland re-
gions that are far from state capitals. The aim of the
present study was to investigate the prevalence of wound
colonization by Staphylococcus sp., especially S. aureus
and MRSA, in patients admitted to a public hospital in
an inland region of northeastern Brazil, and to evaluate
the factors associated with such colonization.
Methods
Study area and design
This 1-year cross-sectional study enrolled patients with
wounds who were admitted to the Hospital Regional do
Serido, municipality of Caico, state of Rio Grande do
Norte, Brazil. Caico is located in an inland region of
northeastern Brazil and covers an area of 1228.6 km2.
The Hospital Regional do Serido is a referral hospital for
patients from the inland part of Rio Grande do Norte,
which treats patients from more than 14 municipalities,
with an average of 2,000 admissions per year. The hos-
pital includes 29 medical beds, 47 surgical beds, and 5
intensive care unit (ICU) beds. The study population
lives in a remote and underdeveloped region.
Study population, sample size, and sampling procedures
All patients aged 18 years or older who were admitted to
the medical ward, surgical ward, or ICU of the Hospital
Regional do Serido with one or more infected wounds
on days allocated for data gathering during 2012 were
included in the study. Patients with wounds treated only
in the outpatient clinics were not included in the study.
Most patients (71.80%) had only one wound, and the
remaining patients had two or more wounds each. As
each wound was swabbed and included in the study,
some patients were included more than once. The sam-
pling unit of the survey was the wound. Data collection
occurred on Monday, Tuesday, and Wednesday of each
week, to enable performance of routine laboratory pro-
cedures. A total of 125 infected wounds were swabbed.
Nasal swabs were also taken from all enrolled patients, as
nasal colonization by Staphylococcus spp. and S. aureus
were independent variables in the study.
Data collection procedures and collection of
microbiological samples
A structured questionnaire was used to collect socioeco-
nomic and demographic data from patients, including
age, sex, years of school education, area of residence
(rural or urban), marital status, number of children, and
number of consumer goods available at home (car or
motorcycle, internet access, and electronic goods includ-
ing television, mobile phone, computer, DVD player, and
stereo). The questionnaire also collected data regarding
prior hospital admissions (within the past year), prior
antibiotic use (within the past 6 months), and the time
the wound was acquired. The medical records were
reviewed to obtain information regarding the time of
hospitalization, reason for hospitalization, antibiotic use,
wound characteristics, and comorbidities. Chronic dis-
eases (such as diabetes mellitus, hypertension, and liver
dysfunction), conditions causing immunocompromise
(such as organ transplantation, immunosuppressant medi-
cation, cancer, HIV infection, leukemia, and anemia), and
opportunistic diseases were recorded.
After debridement of the wound edges and cleaning
with physiological saline, the deepest part of the wound
was swabbed with a sterile swab dipped in 0.85% saline
solution. Both nostrils of each patient were also swabbed
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with a sterile swab dipped in 0.85% saline solution. The
diameter and characteristics (pus, edema, erythema, and
necrosis) of each wound, the hospitalization period, and
the clinical outcome (discharge, transfer, or death) were
recorded.
Culture and microbial identification
All swabs were placed in sterile tubes containing brain
heart infusion broth, and transported to the microbiol-
ogy laboratory of the Caico Campus of the Universidade
do Estado do Rio Grande do Norte in a cooler with ice.
At the laboratory, the samples were incubated at 37°C
for 24 h, after which 0.1-mL samples were seeded onto
mannitol salt agar and incubated in a bacterial incubator
at 37°C for 48 h. Colonies suggestive of staphylococci
underwent Gram staining and catalase and coagulase
testing. Colonies with Gram-positive cocci that were
catalase-positive and coagulase-positive were classified as
presumptive S. aureus, and colonies with Gram-positive
cocci that were coagulase-negative were classified as
coagulase-negative Staphylococcus spp. [22]. As it was not
possible to perform polymerase chain reaction (PCR) amp-
lification to confirm the species at this stage, colonies were
classified as presumptive S. aureus, and PCR was per-
formed for MRSA strains only.
MRSA screening and PCR amplification for detection of
the mecA gene
Colonies identified as presumptive S. aureus underwent
susceptibility testing using the disc diffusion method
in Mueller–Hinton agar. Resistance to cefoxitin 30 μg
(DME-Sensidisc®, Brazil) was tested to identify colonies
as MRSA or methicillin-sensitive S. aureus, in accord-
ance with the Clinical and Laboratory Standards Institute
guidelines (2013) [22]. S. aureus ATCC 25923 was used
as the quality control for antimicrobial susceptibility
tests. To identify MRSA colonies, total DNA extraction
was performed on the samples that were resistant to cefox-
itin [23], followed by PCR amplification for detection of
the mecA gene as described by Oliveira and De Lencastre
in 2002 [24].
Statistical analysis
Wound colonization with Staphylococcus spp. and
S. aureus were considered as dependent variables. Rela-
tionships between variables were analyzed using the
chi-square test or Fisher's exact test, with the crude
prevalence ratio used to determine the magnitude of
associations. To analyze the relationships between vari-
ables, the quantitative variables were converted to categor-
ical variables using their median values. Multivariable
analysis was performed using the Poisson regression
model with robust variance [25,26], including the variables
with values of p < 0.20 on bivariate analysis and important
adjustment variables. The adjusted prevalence ratio was
used to determine the magnitude of associations on multi-
variable analysis. Differences were considered signifi-
cant at p < 0.05 in all tests. All statistical analyses were
performed using Stata statistical software, release 10.0
(College Station, TX).
Ethical considerations
All patients gave written informed consent for inclusion
in the study. The study was approved by the Research
Ethics Committee of the Universidade do Estado do Rio
Grande do Norte (protocol number 001/11).
Results
The sociodemographic characteristics of the enrolled
patients are shown in Table 1. There were no signifi-
cant associations between sociodemographic charac-
teristics and wound colonization by Staphylococcus spp.
or S. aureus. Eighty-five of the 125 wounds swabbed
(68%) were from patients in the medical ward, 20 (16%)
were from patients in the surgical ward, and 20 (16%)
were from patients in the ICU. The mean period of
hospitalization was 8.60 ± 6.35 days, and the mean num-
ber of antibiotics used was 2.08 ± 0.92. Among patients
with wound colonization by Staphylococcus spp., 72%
were prescribed more than one antibiotic, including a
cephalosporin in 90% of cases (usually third or fourth
generation), ciprofloxacin in 48% of cases, and oxacillin in
23% of cases. However, there was no established pattern
Table 1 Sociodemographic characteristics of hospitalized
patients











Age 63.88 ± 18.57
School education (years) 3.84 ± 3.70
Persons per household 4.40 ± 3.12
Children per household 3.18 ± 3.23
Number of consumer goods 8.00 ± 3.95
Urban area = inside the city limits of a town or village, defined by a municipal
area. Rural area = a municipality outside the city limits. An area of agricultural
activities and livestock, rural tourism, forestry, or environmental conservation
(Instituto Brasileiro de Geografia e Estatística).
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for the treatment of wound colonization by Staphylococcus
spp., with more than 20 antibiotics in eight groups used.
Among wounds colonized by Staphylococcus spp.,
79 (63.20%) were in patients with prior hospitalization, 49
(39.20%) were in patients with prior antibiotic use,
59 (47.20%) were in patients with diabetes mellitus, 66
(52.80%) were in patients with cardiovascular disease,
26 (20.80%) were in patients with pneumonia or other
respiratory disease, 18 (14.40%) were in patients with
cancer, 35 (28%) were in patients with paralysis or other
mobility disorder, and 18 (14.40%) were in patients with
septicemia. The mean wound diameter was 7 ± 6.19 cm,
and 63 wounds (50.40%) had been acquired within the
past 30 days. Only 21 (25.92%) of the wounds colonized
by Staphylococcus spp. were acquired in hospital.
The prevalence of Staphylococcus spp. colonization in
wounds was 64.80% (n = 81; 95% confidence interval
[CI] 56.40–73.20), the prevalence of S. aureus colonization
was 20% (n = 25; 95% CI 12.98–27.02), and the preva-
lence of MRSA colonization was 6.40% (n = 8; 95% CI
6.30–6.50). Among wounds colonized by Staphylococcus
spp., 30.86% were colonized by S. aureus, of which 32%
were colonized by MRSA. The majority (n = 5; 62.50%)
of wounds colonized by MRSA were in female patients,
and 2 (25%) were in patients with prior hospitalization.
Among wounds colonized by MRSA, 3 (37.50%) were
in patients with prior antibiotic use, 6 (75%) were in
patients with two or more comorbidities, 2 (25%) were
in patients with cancer or diabetes mellitus, 4 (50%)
were in patients with cardiovascular disease, 6 (75%)
were in patients who received two or more antibiotics,
and 4 (50%) were in patients who died. Among wounds
colonized by MRSA, necrosis occurred in 4 (50%) and
septicemia occurred in 1 (12.50%). All patients with wound
colonization by MRSA also had nasal colonization by
MRSA. Most of the wounds (n = 6; 75%) colonized by
MRSA were acquired in the community.
There were no significant associations between wound
colonization by Staphylococcus spp. and comorbidi-
ties, except for pneumonia or other respiratory disease
(p = 0.03). There were also no significant associations
between wound colonization by S. aureus and comor-
bidities. However, there were significant associations
between nasal colonization by S. aureus and wound
colonization by Staphylococcus spp. (p = 0.05) and S. aureus
(p = 0.003). The relationships between wound colonization
by Staphylococcus spp. and S. aureus and hospitalization
variables and wound characteristics are shown Table 2.
Wound colonization by S. aureus was significantly associ-
ated with nasal colonization by S. aureus, fewer days of
prior antibiotic use, and admission to the medical ward.
Acquisition of the wound in the community was close
to the threshold for significant association with wound
colonization by S. aureus.
Although there were no significantly associations
between wound colonization by Staphylococcus spp.
or S. aureus and the duration of hospitalization, the
hospitalization period was longer in patients with hospital-
acquired wounds than in patients with community-
acquired wounds (p = 0.04).
The multivariable analysis included sex in addition to
the variables with p < 0.20 on bivariate analysis, as this
was an important adjustment variable in multiple models.
Multivariable analysis found that wound colonization by
S. aureus was independently associated with nasal
colonization by S. aureus, fewer days of prior antibiotic
use, and admission to the medical ward. Age was close to
the threshold for independent association with wound
colonization by S. aureus (Table 3).
Discussion
The frequency of wound colonization by S. aureus was
lower in the present study than the frequency of >30% in
the majority of previously reported studies [4,9,11,27,28].
This can be attributed to almost 40% of the wounds in
the present study being in patients with prior antibiotic
use, of which more than 60% had a history of prior
hospitalization, which may have decreased the rate of
colonization by methicillin-sensitive S. aureus. However,
slightly over 30% of the wounds colonized by Staphylo-
coccus spp. were colonized by S. aureus, which is higher
than the proportion of 18% reported in a study of iso-
lates from blood cultures and secretions of hospitalized
patients in a teaching hospital in Natal, the capital city
of the state where the present study was conducted
[29]. This confirms that regional characteristics of the
population and healthcare processes influence the mi-
crobial profiles of hospitals.
In this study, slightly over 30% of the wounds colo-
nized by S. aureus were colonized by MRSA, which is
similar to previously reported findings [3,28,30-32]. Even
though the present study found a lower rate of wound
colonization by S. aureus than in studies conducted in
other regions and other countries, the rate of antibiotic
resistance was high, which may be attributed to prior
antibiotic use by more than a third of the patients, the
majority of whom were elderly with comorbidities, and
use of multiple antibiotics. Some of the patients also had
a history of prior hospitalization. All of these factors
may have resulted in selection of weaker bacterial
strains, which are generally associated with the pres-
ence of MRSA [33-35]. The colonization of wounds by
MRSA indicates a need for greater control to ensure
the proper use of antibiotics, and careful management of
hospitalized patients and the hospital environment to avoid
cross-contamination and the spread of antibiotic-resistant
bacteria in the hospital. In the present study, half of the
wounds colonized by MRSA were in patients with cardiac
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Table 2 Associations between wound colonization by Staphylococcus spp. and Staphylococcus aureus, and hospitalization
variables and wound characteristics
Wound colonization by Staphylococcus spp. Wound colonization by S. aureus
Yes No p PR Yes No p PR
n (%) n (%) (95% CI) n (%) n (%) (95% CI)
Type of ward
Medical 55 (65.90) 29 (34.10) 0.87 1.05 22 (25.90) 63 (74.10) 0.03 3.45
Surgical or ICU 25 (62.50) 15 (37.50) (0.79-1.40) 3 (7.50) 37 (92.50) (1.10-10.86)
Length of hospitalization
≥7 days 36 (57.10) 27 (42.90) 0.10 0.79 10 (15.90) 53 (84.10) 0.35 0.66
<7 days 45 (72.60) 17 (27.40) (0.60-1.02) 15 (24.20) 47 (75.80) (0.32-1.35)
Prior antibiotic use
≥3 days 37 (58.70) 26 (41.30) 0.21 0.83 6 (9.50) 57 (90.50) 0.01 0.31
<3 days 44 (71.00) 18 (29.00) (0.64-1.07) 19 (30.60) 43 (69.40) (0.13-0.73)
Clinical outcome
Death 31 (64.60) 17 (35.40) 1.00 1.01 11 (22.90) 37 (77.10) 0.60 1.32
Discharge or transfer 48 (64.00) 27 (36.00) (0.77-1.32) 13 (17.30) 62 (82.70) (0.65-2.71)
Prior hospitalization
Yes 49 (62.00) 30 (38.00) 0.51 0.89 12 (15.20) 67 (84.80) 0.13 0.54
No 32 (69.60) 14 (30.40) (0.69-1.15) 13 (28.30) 33 (11.70) (0.27-1.08)
Prior antibiotic use
Yes 28 (57.10) 21 (42.90) 0.21 0.82 8 (16.30) 41 (83.70) 0.55 0.73
No 53 (69.70) 23 (30.30) (0.62-1.09) 17 (22.40) 59 (77.60) (0.34-1.56)
Wound acquisition
Hospital 21 (67.70) 10 (32.30) 0.86 1.06 2 (6.50) 29 (93.50) 0.05 0.26
Community 60 (63.80) 34 (36.20) (0.80-1.41) 23 (24.50) 71 (75.50) (0.07-1.05)
Wound type
Pressure ulcer 40 (63.50) 23 (36.50) 0.90 0.96 11 (17.50) 52 (82.50) 0.62 0.77
Diabetic foot or other 41 (66.10) 21 (33.90) (0.74-1.24) 14 (22.60) 48 (77.40) (0.38-1.57)
Wound site
Lower limb 43 (66.20) 22 (33.80) 0.89 1.04 17 (26.20) 48 (73.80) 0.12 1.96
Sacral or other 38 (63.30) 22 (36.70) (0.81-1.35) 8 (13.30) 52 (86.70) (0.91-4.21)
Wound duration
≤30 days 43 (68.30) 20 (31.70) 0.53 1.11 10 (15.90) 53 (84.10) 0.35 0.66
>30 days 38 (61.30) 24 (38.70) (0.86-1.44) 15 (24.20) 47 (75.80) (0.32-1.35)
Wound diameter
>5 cm 36 (58.10) 26 (41.90) 0.17 0.81 13 (21.00) 49 (79.00) 0.79 1.10
≤5 cm 45 (71.40) 18 (28.60) (0.62-1.06) 12 (19.00) 51 (81.00) (0.55-2.22)
Wound pus
Yes 22 (71.00) 9 (29.00) 0.54 1.13 9 (29.00) 22 (71.00) 0.23 1.71
No 59 (62.80) 35 (37.20) (0.86-1.49) 16 (17.00) 78 (83.00) (0.80-3.46)
Wound necrosis
Yes 41 (57.70) 30 (42.30) 0.09 0.78 13 (18.30) 58 (81.70) 0.75 0.82
No 40 (74.10) 14 (25.90) (0.60-1.00) 12 (22.20) 42 (77.80) (0.41-1.66)
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disease, and the great majority were in patients with two or
more comorbidities.
It is worth noting that Staphylococcus spp. are not the
only organisms that colonize wounds. Wound infections
can also be caused by various other microorganisms,
such as group A streptococci (particularly Streptococcus
pyogenes), Escherichia coli, Pseudomonas aeruginosa, and
other Gram-negative bacteria, which may present in isola-
tion or may cause polymicrobial infections that include
Staphylococcus spp. [36-39].
A study conducted in Denmark found that patients
with nasal colonization by S. aureus had the same clone
of S. aureus in their chronic ulcers [40], indicating that
nasal colonization is an important source of wound
contamination in the same patient, as well as cross-
contamination among patients. In the present study,
nasal colonization by S. aureus was associated with
wound colonization by Staphylococcus spp and S. aureus,
and all patients with wound colonization by MRSA
also had nasal colonization by MRSA. These results in-
dicate that nasal colonization is an important source
of cross-contamination by multidrug-resistant bacterial
strains [41].
Some studies reported that community-acquired
wounds are often poorly managed and may be colonized
by multidrug-resistant organisms [42,43]. Most of the
wounds included in the present study were acquired in
the community, which may contribute to the high fre-
quency of colonization by antibiotic-resistant strains. How-
ever, it is difficult to determine whether colonization by
Staphylococcus spp. occurred in the community or the
hospital, even when the wounds were acquired in the
community, because most patients had a history of prior
hospitalization and the great majority had other systemic
diseases. To determine that colonization by MRSA is
community-acquired, MRSA must be isolated from a pa-
tient who has not recently been hospitalized, used anti-
biotics, or had a catheter placed [44].
In the present study, half of the wounds colonized by
MRSA were in patients who died, and the majority were
in patients with two or more comorbidities, and who re-
ceived two or more antibiotics during their hospitalization.
Table 2 Associations between wound colonization by Staphylococcus spp. and Staphylococcus aureus, and hospitalization
variables and wound characteristics (Continued)
Foul wound odor
Yes 13 (56.50) 10 (43.50) 0.50 0.85 6 (26.10) 17 (73.90) 0.40 1.40
No 68 (66.70) 34 (33.30) (0.58-1.24) 19 (18.60) 83 (81.40) (0.63-3.11)
Table 3 Multivariable analysis of factors associated with wound colonization by Staphylococcus aureus
Independent variables Wound colonization by S. aureus p PR (95% CI) p PRadjusted
(95% CI)Absent Present
n (%) n (%)
Nasal S. aureus Present 6 (28.60) 15 (71.40) <0.001 7.43 <0.001 4.39
Absent 94 (90.40) 10 (9.60) (3.88-14.21) (2.22-8.66)
Prior antibiotic use ≥3 days 57 (90.50) 6 (9.50) 0.01 0.31 0.04 0.49
<3 days 43 (69.40) 19 (30.60) (0.13-0.73) (0.25-0.99)
Type of ward Medical 63 (74.10) 22 (25.90) 0.03 3.45 0.02 3.06
Surgical or ICU 37 (92.50) 3 (7.50) (1.10-10.86) (1.15-8.14)
Marital status Unmarried 58 (74.40) 20 (25.60) 0.07 2.41 0.64 1.27
Married 42 (89.40) 5 (10.60) (0.97-5.99) (0.46-3.45)
Wound acquisition Hospital 29 (93.50) 2 (6.50) 0.05 0.26 0.16 0.38
Community 71 (75.50) 23 (24.50) (0.07-1.05) (0.10-1.46)
Prior hospitalization Yes 67 (84.80) 12 (15.20) 0.13 0.54 0.40 0.76
No 33 (71.70) 13 (28.30) (0.27-1.08) (0.40-1.44)
Age ≥65 years 46 (74.20) 16 (25.80) 0.17 1.81 0.05 1.92
<65 years 54 (85.70) 9 (14.30) (0.86-3.78) (0.99-3.75)
Sex Male 48 (76.20) 15 (23.80) 0.39 1.48 0.90 1.04
Female 52 (83.90) 10 (16.10) (0.72-3.30) (0.52-2.10)
Model fit (chi-square test): p = 0.79.
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This illustrates the relationship between colonization by
antibiotic-resistant bacterial strains and the presence of
comorbidities that cause systemic vulnerability. Educa-
tional campaigns can reduce the spread of MRSA in
the community [43], and such campaigns should be
promoted in public hospitals, especially when the popu-
lation has a limited education. The patients enrolled in
the present study had a mean period of education of
4 years, and more than a third of the local population
works in agriculture.
Strategies for prevention and control of infection are
very important in the region studied, where wound in-
fections caused by MRSA are not common and many
patients with wound colonization by MRSA have previ-
ously been hospitalized or used antibiotics. Moreover,
patients with wound colonization by MRSA had a high
mortality rate. It is therefore necessary to investigate the
routines of the staff responsible for wound care, and
use the results of such investigations to promote train-
ing regarding the prevention of cross-contamination in
hospitals.
The present study provides a profile of wound
colonization by Staphylococcus spp. in patients in an
undeveloped region of Brazil with extreme poverty.
However, the study has some important limitations. PCR
amplification for identification of S. aureus, and molecu-
lar type classification for identification of MRSA strains
were not performed. The nasal swab results may give
an indication of the prevalence of methicillin-sensitive
S. aureus and MRSA in the community, but the MRSA
strains in the community were not identified. Other skin
areas could be also have been investigated as potential
carriers of MRSA. Moreover, it was not possible to collect
swabs on all days of the week, or to include wounds
treated in outpatient clinics, which may have introduced
selection bias.
Conclusions
The present study found a high frequency of wound
colonization by Staphylococcus spp. and moderate fre-
quency of wound colonization by S. aureus. The propor-
tion of wounds colonized by MRSA was high in this
study compared with other studies. Knowledge about
the colonization patterns of these microorganisms in the
hospital environment is important, because of their abil-
ity to acquire resistance, which can lead to prolonged
hospitalization and treatment difficulty. Nasal colonization
by S. aureus is an important source of wound colonization
by S. aureus, which illustrates the importance of prevent-
ing cross-contamination. Our results reinforce the need
for prevention and control of hospital- and community-
acquired infections, especially among elderly patients,
who may need longer treatment and larger numbers
of medications, and may have more comorbidities, than
younger patients. In conclusion, wounds are a source of
Staphylococcus spp. infection, and should be the focus
of prevention and control strategies to avoid microbial
spread, assist in patient treatment, and minimize hospi-
talization costs.
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